| abstract |
The invention discloses an enhanced animal gene vaccine carrier, which comprises the following components and mass content: the mass content of genetic vaccine structural protein is 2.5-4.8 parts, supramolecular hydrogel is 15.3-27.6 parts, mineral oil adjuvant 3.4‑6.8 parts, phosphatase 0.5‑0.75 parts and kanamycin resistance gene. The enhanced animal gene vaccine carrier of the invention can enhance the immunogenicity, enhance the titer of antibody vaccine, and reduce the occurrence of side effects. |